CLINICAL_TRIALS
trial_result
· 2023-10-02
Clinical Trial Update: Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension [Phase 4]
Summary
Phase 4 trial update reporting efficacy and tolerance of Flucortac in patients with neurogenic orthostatic hypotension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H.A.C. PHARMA | Conditions: Neurogenic Orthostatic Hypotension | Phase 4 | Status: UNKNOWN